Obesity Drug
-
{
- All
- News
- Videos
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
- Wednesday April 15, 2026
- Health | Written by Sambhav Kumar
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
www.ndtv.com
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
- Tuesday April 14, 2026
- Health | Reported by Tanushka Dutta
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
www.ndtv.com
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
- Saturday April 11, 2026
- Health | Written by Debosmita Ghosh
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
www.ndtv.com
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
- Monday April 6, 2026
- Health | Written by Debosmita Ghosh
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
www.ndtv.com
-
With Rs 13,000-25,000 Per Dose, Weight-Loss Drugs Are Changing Indian Weddings For Brides
- Friday April 3, 2026
- Lifestyle | Reuters
The lowest Mounjaro injection pen dose sells for Rs 13,125 per month, while the highest dose costs Rs 25,781. Novo is selling the lowest Wegovy dose for Rs 5,660 and the highest for Rs 16,400 a month
-
www.ndtv.com/lifestyle
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
- Thursday April 2, 2026
- Science | Edited by Nikhil Pandey
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
www.ndtv.com
-
Semaglutide Weight-Loss Drugs May Help Prevent Deadly Heart Attack Complications
- Monday March 30, 2026
- Written by Shreya Goswami
Popular weight-loss drugs like semaglutide may reduce life-threatening complications after heart attacks, a UK study finds. By improving blood flow in tiny vessels, these drugs could help the heart recover, but human trials are still needed.
-
doctor.ndtv.com
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
- Monday March 30, 2026
- Health | Asian News International
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
www.ndtv.com
-
ICMR-NIN Develops Herbal Formulation To Tackle Diabetes, Obesity
- Wednesday March 25, 2026
- Health | Reported by Tanushka Dutta
The ICMR-National Institute of Nutrition has developed a poly-herbal extract that goes beyond blood sugar control to target complications linked to diabetes and obesity, including kidney damage, vision loss, and nerve disorders.
-
www.ndtv.com
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
- Wednesday April 15, 2026
- Health | Written by Sambhav Kumar
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
www.ndtv.com
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
- Tuesday April 14, 2026
- Health | Reported by Tanushka Dutta
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
www.ndtv.com
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
- Saturday April 11, 2026
- Health | Written by Debosmita Ghosh
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
www.ndtv.com
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
- Monday April 6, 2026
- Health | Written by Debosmita Ghosh
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
www.ndtv.com
-
With Rs 13,000-25,000 Per Dose, Weight-Loss Drugs Are Changing Indian Weddings For Brides
- Friday April 3, 2026
- Lifestyle | Reuters
The lowest Mounjaro injection pen dose sells for Rs 13,125 per month, while the highest dose costs Rs 25,781. Novo is selling the lowest Wegovy dose for Rs 5,660 and the highest for Rs 16,400 a month
-
www.ndtv.com/lifestyle
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
- Thursday April 2, 2026
- Science | Edited by Nikhil Pandey
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
www.ndtv.com
-
Semaglutide Weight-Loss Drugs May Help Prevent Deadly Heart Attack Complications
- Monday March 30, 2026
- Written by Shreya Goswami
Popular weight-loss drugs like semaglutide may reduce life-threatening complications after heart attacks, a UK study finds. By improving blood flow in tiny vessels, these drugs could help the heart recover, but human trials are still needed.
-
doctor.ndtv.com
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
- Monday March 30, 2026
- Health | Asian News International
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
www.ndtv.com
-
ICMR-NIN Develops Herbal Formulation To Tackle Diabetes, Obesity
- Wednesday March 25, 2026
- Health | Reported by Tanushka Dutta
The ICMR-National Institute of Nutrition has developed a poly-herbal extract that goes beyond blood sugar control to target complications linked to diabetes and obesity, including kidney damage, vision loss, and nerve disorders.
-
www.ndtv.com